Display options
Cite
Wáng YX, Xiao F. Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002. Quant Imaging Med Surg. 2015;5(3):453-66doi: 10.3978/j.issn.2223-4292.2015.03.10.
Wáng, Y. X., & Xiao, F. (2015). Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002. Quantitative imaging in medicine and surgery, 5(3), 453-66. https://doi.org/10.3978/j.issn.2223-4292.2015.03.10
Wáng, Yì-Xiáng J, and Xiao, Fan. "Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002." Quantitative imaging in medicine and surgery vol. 5,3 (2015): 453-66. doi: https://doi.org/10.3978/j.issn.2223-4292.2015.03.10
Wáng YX, Xiao F. Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002. Quant Imaging Med Surg. 2015 Jun;5(3):453-66. doi: 10.3978/j.issn.2223-4292.2015.03.10. PMID: 26029648; PMCID: PMC4426111.
Copy Download .nbib Format: NLM
Share it on

Quant Imaging Med Surg. 2015 Jun;5(3):453-66. doi: 10.3978/j.issn.2223-4292.2015.03.10.

Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.

Quantitative imaging in medicine and surgery

Yì-Xiáng J Wáng, Fan Xiao

Affiliations

  1. Department of Imaging and Interventional Radiology, Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, New Territories, Hong Kong SAR, China.

PMID: 26029648 PMCID: PMC4426111 DOI: 10.3978/j.issn.2223-4292.2015.03.10

Abstract

OBJECTIVE: This survey aims to scrutinize important medical innovations in Chinese mainland since Xinhai (Hsin-hai) revolution in 1911, which marked the end of Manchurian imperial rule and the beginning of China's republican era.

METHODS: An online cross-sectional survey was carried out during the period of Dec 29, 2014 to Feb 5, 2015, totaling 37 days. The survey was conducted on the platform provided by DXY (www.dxy.cn), which is the largest medical and paramedical related website in China. An email was sent to all DXY registered users to invite them to participate in a 5-minute survey. The participants were asked to nominate up to four important medical innovations in China mainland since Xinhai revolution. The participant could select 'zero' which means he/she felt there was no important medical innovations, or he/she did not know important medical innovations. It was noted that important medical innovations refer to (I) those with practical and almost immediate significance to improve healthcare; (II) should not only be introducing western technique to China, but those involve major improvement of existing western techniques count; (III) should not be those with important theoretical discovery but did not have almost immediate significance to improve healthcare.

RESULTS: In total 1,513 DXY users participated in the voting. Totally 489 (32.3%), 441 (29.1%), 342 (22.6%), 150 (9.9%), 91 (6.0%) participants provided 0, 1, 2, 3, 4 nominations respectively. (I) Artemisine (Qinghaosu) for malaria treatment (Project 523 team, 1972); (II) arsenic Trioxide (As2O3) for acute promyelocytic leukemia (APL) treatment (ZHANG Ting-Dong and colleagues, 1970s); (III) limb re-plantation (CHEN Zhong-Wei and colleagues, 1963); (IV) all-trans retinoic acid (ATRA) for APL treatment (WANG Zhen-Yi and colleagues, 1988); and (V) Wu's mask for plague prevention (WU Lien-The, 1910), were voted as the top five innovations in China mainland since Xinhai revolution, with 375, 96, 91, 53, and 8 votes respectively.

CONCLUSIONS: In this voting exercise, five achievements were voted as top innovations in China mainland since Xinhai revolution. However, only ATRA for APL treatment was accomplished after the ending of Great Proletarian Cultural Revolution in year 1976 in China.

Keywords: Technology innovation; dialectics of nature; history of science; history of technology; inventions and discoveries

References

  1. Blood. 1991 Sep 15;78(6):1413-9 - PubMed
  2. Science. 1985 May 31;228(4703):1049-55 - PubMed
  3. Lancet. 2005 Jul 9-15;366(9480):136-43 - PubMed
  4. Hong Kong Med J. 2011 Dec;17(6):507-13 - PubMed
  5. Ann Oncol. 2003 May;14(5):752-7 - PubMed
  6. Sci Sin. 1965 Nov;14(11):1710-6 - PubMed
  7. Chin Med J (Engl). 1975 May;1(3):184-96 - PubMed
  8. Arch Intern Med. 2012 Oct 22;172(19):1444-53 - PubMed
  9. J Clin Pathol. 1956 May;9(2):83-93 - PubMed
  10. Biochem J. 1951 Sep;49(4):463-81 - PubMed
  11. Oncologist. 2001;6 Suppl 2:1-2 - PubMed
  12. Blood. 2002 Dec 15;100(13):4298-302 - PubMed
  13. Blood. 1981 Jun;57(6):1000-4 - PubMed
  14. Blood. 2003 Jul 1;102(1):407-8 - PubMed
  15. Hand (N Y). 2011 Dec;6(4):356-63 - PubMed
  16. BMJ. 2005 Aug 13;331(7513):376-82 - PubMed
  17. Trans Am Ophthalmol Soc. 1940;38:111-24 - PubMed
  18. Microsurgery. 2002;22(1):39-43 - PubMed
  19. Chin Med J. 1963 Oct;82:633-8 - PubMed
  20. Br J Haematol. 1984 Jul;57(3):365-71 - PubMed
  21. Z Naturforsch B. 1963 Dec;18:1120-1 - PubMed
  22. Eur J Cancer Clin Oncol. 1983 Feb;19(2):251-61 - PubMed
  23. J Bone Joint Surg Am. 1963 Jun;45-A:788-96 - PubMed
  24. N Engl J Med. 1991 May 16;324(20):1385-93 - PubMed
  25. Appl Microbiol Biotechnol. 2000 Sep;54(3):277-86 - PubMed
  26. Microsurgery. 2002;22(1):5-10 - PubMed
  27. Chin Med J (Engl). 1979 Dec;92(12):811-6 - PubMed
  28. Chin Med J (Engl). 1987 Dec;100(12):949-53 - PubMed
  29. Science. 1906 Mar 9;23(584):393-4 - PubMed
  30. Plast Reconstr Surg. 2009 Dec;124(6 Suppl):e282-94 - PubMed
  31. Blood. 1990 Nov 1;76(9):1704-9 - PubMed
  32. World J Surg. 1995 May-Jun;19(3):462-7 - PubMed
  33. JAMA. 1964 Sep 7;189:716-22 - PubMed
  34. Blood. 1986 Feb;67(2):559-61 - PubMed
  35. Sci China Life Sci. 2013 Jun;56(6):495-502 - PubMed
  36. Acta Microbiol Immunol Hung. 2007 Mar;54(1):5-22 - PubMed
  37. Biochem J. 1953 Feb;53(3):366-74 - PubMed
  38. Arch Intern Med. 2009 May 11;169(9):858-66 - PubMed
  39. Can Med Assoc J. 1922 Mar;12(3):141-6 - PubMed
  40. Lancet. 1958 May 10;1(7028):993-6 - PubMed
  41. Blood. 1997 May 1;89(9):3487-8 - PubMed
  42. Am J Pathol. 1931 May;7(3):209-222.5 - PubMed
  43. Lancet. 1989 Sep 23;2(8665):746-7 - PubMed
  44. Biochem Soc Trans. 2011 Oct;39(5):1323-6 - PubMed
  45. Blood. 1988 Aug;72(2):567-72 - PubMed
  46. Ann Surg. 1963 Jun;157(6):944-59 - PubMed
  47. BMJ. 2009 Jan 27;338:a3115 - PubMed
  48. Blood. 2011 Dec 15;118(25):6535-43 - PubMed
  49. Plast Reconstr Surg. 1973 Nov;52(5):476-89 - PubMed
  50. N Engl J Med. 1998 Nov 5;339(19):1341-8 - PubMed
  51. Pain. 2011 Apr;152(4):755-64 - PubMed
  52. Chin Med J. 1957 Jun;75(6):429-47 - PubMed
  53. Pain. 2009 Dec;146(3):238-44 - PubMed
  54. Nat Biotechnol. 2012 Oct;30(10):923-6 - PubMed
  55. Blood. 1983 Dec;62(6):1211-7 - PubMed
  56. Biochem J. 1951 Sep;49(4):481-90 - PubMed
  57. JAMA. 2005 May 4;293(17):2118-25 - PubMed
  58. Chin J Cancer Res. 2015 Feb;27(1):94-5 - PubMed
  59. Lancet. 1959 May 2;1(7079):902-5 - PubMed
  60. J Clin Oncol. 2014 Oct 20;32(30):3406-12 - PubMed
  61. Blood. 1983 Oct;62(4):709-21 - PubMed
  62. Oncogene. 2001 Oct 29;20(49):7140-5 - PubMed
  63. Proc Natl Acad Sci U S A. 1980 May;77(5):2936-40 - PubMed
  64. Br J Haematol. 2002 Apr;117(1):130-2 - PubMed
  65. Cancer. 1986 Jan 15;57(2):209-17 - PubMed
  66. Arch Intern Med. 2007 Sep 24;167(17):1892-8 - PubMed
  67. Biochem J. 1953 Feb;53(3):353-66 - PubMed
  68. N Engl J Med. 2013 Jul 11;369(2):111-21 - PubMed
  69. J Hyg Epidemiol Microbiol Immunol. 1957;1(2):109-20 - PubMed

Publication Types